Answers are grounded in this paper and cite their sources.
IMPRESS I and II support the clinical efficacy and safety of collagenase C. histolyticum for the physical and psychological aspects of Peyronie disease.
No takes yet. Share an insight, caveat, or question.
Gelbard et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: